 | • レポートコード：GIR-105X14863 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ウステキヌマブのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ウステキヌマブの種類別市場規模（静脈内用、皮下用）、用途別市場規模（関節炎、大腸炎、エリテマトーデス、掌蹠膿疱症併発型多重筋炎、肝硬変、サルコイドーシス、糖尿病、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ウステキヌマブの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Meiji、Johnson & Johnson、Alvotech、Fuji Pharma、Mitsubishi Tanabe、Stada、EPIRUS BioPharma、Formycon、NeuClone、Outlook Therapeutics、Harvest Moon Pharma、BioXpress ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：静脈内用、皮下用 ・用途別分析2016年-2026年：関節炎、大腸炎、エリテマトーデス、掌蹠膿疱症併発型多重筋炎、肝硬変、サルコイドーシス、糖尿病、その他 ・ウステキヌマブの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ウステキヌマブのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ウステキヌマブのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ウステキヌマブの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ウステキヌマブの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Ustekinumab market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Ustekinumab size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Ustekinumab market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Ustekinumab market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Intravenous
Subcutaneous
Market segment by Application can be divided into
Arthritis
Colitis
Lupus Erythematosus
Myositis Multiplex With Palmoplantar Pustulosis
Cirrhosis Of The Liver
Sarcoidosis
Diabetes
Other
The key market players for global Ustekinumab market are listed below:
Meiji
Johnson & Johnson
Alvotech
Fuji Pharma
Mitsubishi Tanabe
Stada
EPIRUS BioPharma
Formycon
NeuClone
Outlook Therapeutics
Harvest Moon Pharma
BioXpress
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Ustekinumab product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Ustekinumab, with price, sales, revenue and global market share of Ustekinumab in 2018 and 2019.
Chapter 3, the Ustekinumab competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ustekinumab breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Ustekinumab market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Ustekinumab sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Ustekinumab Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Ustekinumab Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Intravenous
1.2.3 Subcutaneous
1.3 Market Analysis by Application
1.3.1 Overview: Global Ustekinumab Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Arthritis
1.3.3 Colitis
1.3.4 Lupus Erythematosus
1.3.5 Myositis Multiplex With Palmoplantar Pustulosis
1.3.6 Cirrhosis Of The Liver
1.3.7 Sarcoidosis
1.3.8 Diabetes
1.3.9 Other
1.4 Global Ustekinumab Market Size & Forecast
1.4.1 Global Ustekinumab Sales in Value (2016-2026))
1.4.2 Global Ustekinumab Sales in Volume (2016-2026)
1.4.3 Global Ustekinumab Price by Type (2016-2026) & (US$/Unit)
1.5 Global Ustekinumab Production Capacity Analysis
1.5.1 Global Ustekinumab Total Production Capacity (2016-2026)
1.5.2 Global Ustekinumab Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Ustekinumab Market Drivers
1.6.2 Ustekinumab Market Restraints
1.6.3 Ustekinumab Trends Analysis
2 Manufacturers Profiles
2.1 Meiji
2.1.1 Meiji Details
2.1.2 Meiji Major Business
2.1.3 Meiji Ustekinumab Product and Services
2.1.4 Meiji Ustekinumab Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Ustekinumab Product and Services
2.2.4 Johnson & Johnson Ustekinumab Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Alvotech
2.3.1 Alvotech Details
2.3.2 Alvotech Major Business
2.3.3 Alvotech Ustekinumab Product and Services
2.3.4 Alvotech Ustekinumab Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Fuji Pharma
2.4.1 Fuji Pharma Details
2.4.2 Fuji Pharma Major Business
2.4.3 Fuji Pharma Ustekinumab Product and Services
2.4.4 Fuji Pharma Ustekinumab Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Mitsubishi Tanabe
2.5.1 Mitsubishi Tanabe Details
2.5.2 Mitsubishi Tanabe Major Business
2.5.3 Mitsubishi Tanabe Ustekinumab Product and Services
2.5.4 Mitsubishi Tanabe Ustekinumab Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Stada
2.6.1 Stada Details
2.6.2 Stada Major Business
2.6.3 Stada Ustekinumab Product and Services
2.6.4 Stada Ustekinumab Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 EPIRUS BioPharma
2.7.1 EPIRUS BioPharma Details
2.7.2 EPIRUS BioPharma Major Business
2.7.3 EPIRUS BioPharma Ustekinumab Product and Services
2.7.4 EPIRUS BioPharma Ustekinumab Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Formycon
2.8.1 Formycon Details
2.8.2 Formycon Major Business
2.8.3 Formycon Ustekinumab Product and Services
2.8.4 Formycon Ustekinumab Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 NeuClone
2.9.1 NeuClone Details
2.9.2 NeuClone Major Business
2.9.3 NeuClone Ustekinumab Product and Services
2.9.4 NeuClone Ustekinumab Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Outlook Therapeutics
2.10.1 Outlook Therapeutics Details
2.10.2 Outlook Therapeutics Major Business
2.10.3 Outlook Therapeutics Ustekinumab Product and Services
2.10.4 Outlook Therapeutics Ustekinumab Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Harvest Moon Pharma
2.11.1 Harvest Moon Pharma Details
2.11.2 Harvest Moon Pharma Major Business
2.11.3 Harvest Moon Pharma Ustekinumab Product and Services
2.11.4 Harvest Moon Pharma Ustekinumab Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 BioXpress
2.12.1 BioXpress Details
2.12.2 BioXpress Major Business
2.12.3 BioXpress Ustekinumab Product and Services
2.12.4 BioXpress Ustekinumab Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Ustekinumab Sales by Manufacturer
3.1 Global Ustekinumab Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Ustekinumab Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Ustekinumab
3.4 Market Concentration Rate
3.4.1 Top 3 Ustekinumab Manufacturer Market Share
3.4.2 Top 6 Ustekinumab Manufacturer Market Share
3.5 Global Ustekinumab Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Ustekinumab Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Ustekinumab Market Size by Region
4.1.1 Global Ustekinumab Sales in Volume by Region (2016-2026)
4.1.2 Global Ustekinumab Revenue by Region (2016-2026)
4.2 North America Ustekinumab Revenue (2016-2026)
4.3 Europe Ustekinumab Revenue (2016-2026)
4.4 Asia-Pacific Ustekinumab Revenue (2016-2026)
4.5 South America Ustekinumab Revenue (2016-2026)
4.6 Middle East and Africa Ustekinumab Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Ustekinumab Sales in Volume by Type (2016-2026)
5.2 Global Ustekinumab Revenue by Type (2016-2026)
5.3 Global Ustekinumab Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Ustekinumab Sales in Volume by Application (2016-2026)
6.2 Global Ustekinumab Revenue by Application (2016-2026)
6.3 Global Ustekinumab Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Ustekinumab Sales by Type (2016-2026)
7.2 North America Ustekinumab Sales by Application (2016-2026)
7.3 North America Ustekinumab Market Size by Country
7.3.1 North America Ustekinumab Sales in Volume by Country (2016-2026)
7.3.2 North America Ustekinumab Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Ustekinumab Sales by Type (2016-2026)
8.2 Europe Ustekinumab Sales by Application (2016-2026)
8.3 Europe Ustekinumab Market Size by Country
8.3.1 Europe Ustekinumab Sales in Volume by Country (2016-2026)
8.3.2 Europe Ustekinumab Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Ustekinumab Sales by Type (2016-2026)
9.2 Asia-Pacific Ustekinumab Sales by Application (2016-2026)
9.3 Asia-Pacific Ustekinumab Market Size by Region
9.3.1 Asia-Pacific Ustekinumab Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Ustekinumab Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Ustekinumab Sales by Type (2016-2026)
10.2 South America Ustekinumab Sales by Application (2016-2026)
10.3 South America Ustekinumab Market Size by Country
10.3.1 South America Ustekinumab Sales in Volume by Country (2016-2026)
10.3.2 South America Ustekinumab Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Ustekinumab Sales by Type (2016-2026)
11.2 Middle East & Africa Ustekinumab Sales by Application (2016-2026)
11.3 Middle East & Africa Ustekinumab Market Size by Country
11.3.1 Middle East & Africa Ustekinumab Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Ustekinumab Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Ustekinumab Typical Distributors
12.3 Ustekinumab Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Ustekinumab Revenue by Type, (USD Million), 2021-2026
Table 2. Global Ustekinumab Revenue by Application, (USD Million), 2021-2026
Table 3. Meiji Basic Information, Manufacturing Base and Competitors
Table 4. Meiji Major Business
Table 5. Meiji Ustekinumab Product and Services
Table 6. Meiji Ustekinumab Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 8. Johnson & Johnson Major Business
Table 9. Johnson & Johnson Ustekinumab Product and Services
Table 10. Johnson & Johnson Ustekinumab Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Alvotech Basic Information, Manufacturing Base and Competitors
Table 12. Alvotech Major Business
Table 13. Alvotech Ustekinumab Product and Services
Table 14. Alvotech Ustekinumab Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Fuji Pharma Basic Information, Manufacturing Base and Competitors
Table 16. Fuji Pharma Major Business
Table 17. Fuji Pharma Ustekinumab Product and Services
Table 18. Fuji Pharma Ustekinumab Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Mitsubishi Tanabe Basic Information, Manufacturing Base and Competitors
Table 20. Mitsubishi Tanabe Major Business
Table 21. Mitsubishi Tanabe Ustekinumab Product and Services
Table 22. Mitsubishi Tanabe Ustekinumab Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Stada Basic Information, Manufacturing Base and Competitors
Table 24. Stada Major Business
Table 25. Stada Ustekinumab Product and Services
Table 26. Stada Ustekinumab Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. EPIRUS BioPharma Basic Information, Manufacturing Base and Competitors
Table 28. EPIRUS BioPharma Major Business
Table 29. EPIRUS BioPharma Ustekinumab Product and Services
Table 30. EPIRUS BioPharma Ustekinumab Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Formycon Basic Information, Manufacturing Base and Competitors
Table 32. Formycon Major Business
Table 33. Formycon Ustekinumab Product and Services
Table 34. Formycon Ustekinumab Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. NeuClone Basic Information, Manufacturing Base and Competitors
Table 36. NeuClone Major Business
Table 37. NeuClone Ustekinumab Product and Services
Table 38. NeuClone Ustekinumab Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Outlook Therapeutics Basic Information, Manufacturing Base and Competitors
Table 40. Outlook Therapeutics Major Business
Table 41. Outlook Therapeutics Ustekinumab Product and Services
Table 42. Outlook Therapeutics Ustekinumab Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Harvest Moon Pharma Basic Information, Manufacturing Base and Competitors
Table 44. Harvest Moon Pharma Major Business
Table 45. Harvest Moon Pharma Ustekinumab Product and Services
Table 46. Harvest Moon Pharma Ustekinumab Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. BioXpress Basic Information, Manufacturing Base and Competitors
Table 48. BioXpress Major Business
Table 49. BioXpress Ustekinumab Product and Services
Table 50. BioXpress Ustekinumab Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Global Ustekinumab Sales by Manufacturer (2019-2021e) & (K Units)
Table 52. Global Ustekinumab Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 53. Market Position of Manufacturers in Ustekinumab, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 54. Global Ustekinumab Production Capacity by Company, (K Units): 2020 VS 2021
Table 55. Head Office and Ustekinumab Production Site of Key Manufacturer
Table 56. Ustekinumab New Entrant and Capacity Expansion Plans
Table 57. Ustekinumab Mergers & Acquisitions in the Past Five Years
Table 58. Global Ustekinumab Sales by Region (2016-2021e) & (K Units)
Table 59. Global Ustekinumab Sales by Region (2021-2026) & (K Units)
Table 60. Global Ustekinumab Revenue by Region (2016-2021e) & (USD Million)
Table 61. Global Ustekinumab Revenue by Region (2021-2026) & (USD Million)
Table 62. Global Ustekinumab Sales by Type (2016-2021e) & (K Units)
Table 63. Global Ustekinumab Sales by Type (2021-2026) & (K Units)
Table 64. Global Ustekinumab Revenue by Type (2016-2021e) & (USD Million)
Table 65. Global Ustekinumab Revenue by Type (2021-2026) & (USD Million)
Table 66. Global Ustekinumab Price by Type (2016-2021e) & (US$/Unit)
Table 67. Global Ustekinumab Price by Type (2021-2026) & (US$/Unit)
Table 68. Global Ustekinumab Sales by Application (2016-2021e) & (K Units)
Table 69. Global Ustekinumab Sales by Application (2021-2026) & (K Units)
Table 70. Global Ustekinumab Revenue by Application (2016-2021e) & (USD Million)
Table 71. Global Ustekinumab Revenue by Application (2021-2026) & (USD Million)
Table 72. Global Ustekinumab Price by Application (2016-2021e) & (US$/Unit)
Table 73. Global Ustekinumab Price by Application (2021-2026) & (US$/Unit)
Table 74. North America Ustekinumab Sales by Country (2016-2021e) & (K Units)
Table 75. North America Ustekinumab Sales by Country (2021-2026) & (K Units)
Table 76. North America Ustekinumab Revenue by Country (2016-2021e) & (USD Million)
Table 77. North America Ustekinumab Revenue by Country (2021-2026) & (USD Million)
Table 78. North America Ustekinumab Sales by Type (2016-2021e) & (K Units)
Table 79. North America Ustekinumab Sales by Type (2021-2026) & (K Units)
Table 80. North America Ustekinumab Sales by Application (2016-2021e) & (K Units)
Table 81. North America Ustekinumab Sales by Application (2021-2026) & (K Units)
Table 82. Europe Ustekinumab Sales by Country (2016-2021e) & (K Units)
Table 83. Europe Ustekinumab Sales by Country (2021-2026) & (K Units)
Table 84. Europe Ustekinumab Revenue by Country (2016-2021e) & (USD Million)
Table 85. Europe Ustekinumab Revenue by Country (2021-2026) & (USD Million)
Table 86. Europe Ustekinumab Sales by Type (2016-2021e) & (K Units)
Table 87. Europe Ustekinumab Sales by Type (2021-2026) & (K Units)
Table 88. Europe Ustekinumab Sales by Application (2016-2021e) & (K Units)
Table 89. Europe Ustekinumab Sales by Application (2021-2026) & (K Units)
Table 90. Asia-Pacific Ustekinumab Sales by Region (2016-2021e) & (K Units)
Table 91. Asia-Pacific Ustekinumab Sales by Region (2021-2026) & (K Units)
Table 92. Asia-Pacific Ustekinumab Revenue by Region (2016-2021e) & (USD Million)
Table 93. Asia-Pacific Ustekinumab Revenue by Region (2021-2026) & (USD Million)
Table 94. Asia-Pacific Ustekinumab Sales by Type (2016-2021e) & (K Units)
Table 95. Asia-Pacific Ustekinumab Sales by Type (2021-2026) & (K Units)
Table 96. Asia-Pacific Ustekinumab Sales by Application (2016-2021e) & (K Units)
Table 97. Asia-Pacific Ustekinumab Sales by Application (2021-2026) & (K Units)
Table 98. South America Ustekinumab Sales by Country (2016-2021e) & (K Units)
Table 99. South America Ustekinumab Sales by Country (2021-2026) & (K Units)
Table 100. South America Ustekinumab Revenue by Country (2016-2021e) & (USD Million)
Table 101. South America Ustekinumab Revenue by Country (2021-2026) & (USD Million)
Table 102. South America Ustekinumab Sales by Type (2016-2021e) & (K Units)
Table 103. South America Ustekinumab Sales by Type (2021-2026) & (K Units)
Table 104. South America Ustekinumab Sales by Application (2016-2021e) & (K Units)
Table 105. South America Ustekinumab Sales by Application (2021-2026) & (K Units)
Table 106. Middle East & Africa Ustekinumab Sales by Country (2016-2021e) & (K Units)
Table 107. Middle East & Africa Ustekinumab Sales by Country (2021-2026) & (K Units)
Table 108. Middle East & Africa Ustekinumab Revenue by Country (2016-2021e) & (USD Million)
Table 109. Middle East & Africa Ustekinumab Revenue by Country (2021-2026) & (USD Million)
Table 110. Middle East & Africa Ustekinumab Sales by Type (2016-2021e) & (K Units)
Table 111. Middle East & Africa Ustekinumab Sales by Type (2021-2026) & (K Units)
Table 112. Middle East & Africa Ustekinumab Sales by Application (2016-2021e) & (K Units)
Table 113. Middle East & Africa Ustekinumab Sales by Application (2021-2026) & (K Units)
Table 114. Direct Channel Pros & Cons
Table 115. Indirect Channel Pros & Cons
Table 116. Ustekinumab Typical Distributors
Table 117. Ustekinumab Typical Customers
List of Figures
Figure 1. Ustekinumab Picture
Figure 2. Global Ustekinumab Sales Market Share by Type in 2020
Figure 3. Intravenous
Figure 4. Subcutaneous
Figure 5. Global Ustekinumab Sales Market Share by Application in 2020
Figure 6. Arthritis
Figure 7. Colitis
Figure 8. Lupus Erythematosus
Figure 9. Myositis Multiplex With Palmoplantar Pustulosis
Figure 10. Cirrhosis Of The Liver
Figure 11. Sarcoidosis
Figure 12. Diabetes
Figure 13. Other
Figure 14. Global Ustekinumab Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 15. Global Ustekinumab Market Size and Forecast (2016-2026) & (USD Million)
Figure 16. Global Ustekinumab Sales (2016-2026) & (K Units)
Figure 17. Global Ustekinumab Price by Type (2016-2026) & (US$/Unit)
Figure 18. Global Ustekinumab Production Capacity (2016-2026) & (K Units)
Figure 19. Global Ustekinumab Production Capacity by Geographic Region: 2020 VS 2021
Figure 20. Ustekinumab Market Drivers
Figure 21. Ustekinumab Market Restraints
Figure 22. Ustekinumab Market Trends
Figure 23. Global Ustekinumab Sales Market Share by Manufacturer in 2020
Figure 24. Global Ustekinumab Revenue Market Share by Manufacturer in 2020
Figure 25. Ustekinumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 26. Top 3 Ustekinumab Manufacturer (Revenue) Market Share in 2020
Figure 27. Top 6 Ustekinumab Manufacturer (Revenue) Market Share in 2020
Figure 28. Global Ustekinumab Sales Market Share by Region (2016-2026)
Figure 29. Global Ustekinumab Revenue Market Share by Region (2016-2026)
Figure 30. North America Ustekinumab Revenue (2016-2026) & (USD Million)
Figure 31. Europe Ustekinumab Revenue (2016-2026) & (USD Million)
Figure 32. Asia-Pacific Ustekinumab Revenue (2016-2026) & (USD Million)
Figure 33. South America Ustekinumab Revenue (2016-2026) & (USD Million)
Figure 34. Middle East & Africa Ustekinumab Revenue (2016-2026) & (USD Million)
Figure 35. Global Ustekinumab Sales Market Share by Type (2016-2026)
Figure 36. Global Ustekinumab Revenue Market Share by Type (2016-2026)
Figure 37. Global Ustekinumab Price by Type (2016-2026) & (US$/Unit)
Figure 38. Global Ustekinumab Sales Market Share by Application (2016-2026)
Figure 39. Global Ustekinumab Revenue Market Share by Application (2016-2026)
Figure 40. Global Ustekinumab Price by Application (2016-2026) & (US$/Unit)
Figure 41. North America Ustekinumab Sales Market Share by Type (2016-2026)
Figure 42. North America Ustekinumab Sales Market Share by Application (2016-2026)
Figure 43. North America Ustekinumab Sales Market Share by Country (2016-2026)
Figure 44. North America Ustekinumab Revenue Market Share by Country (2016-2026)
Figure 45. United States Ustekinumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Ustekinumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Ustekinumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Ustekinumab Sales Market Share by Type (2016-2026)
Figure 49. Europe Ustekinumab Sales Market Share by Application (2016-2026)
Figure 50. Europe Ustekinumab Sales Market Share by Country (2016-2026)
Figure 51. Europe Ustekinumab Revenue Market Share by Country (2016-2026)
Figure 52. Germany Ustekinumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Ustekinumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Ustekinumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Ustekinumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Ustekinumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Ustekinumab Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Ustekinumab Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Ustekinumab Sales Market Share by Region (2016-2026)
Figure 60. Asia-Pacific Ustekinumab Revenue Market Share by Region (2016-2026)
Figure 61. China Ustekinumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Japan Ustekinumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Korea Ustekinumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. India Ustekinumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Southeast Asia Ustekinumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Australia Ustekinumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South America Ustekinumab Sales Market Share by Type (2016-2026)
Figure 68. South America Ustekinumab Sales Market Share by Application (2016-2026)
Figure 69. South America Ustekinumab Sales Market Share by Country (2016-2026)
Figure 70. South America Ustekinumab Revenue Market Share by Country (2016-2026)
Figure 71. Brazil Ustekinumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina Ustekinumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East & Africa Ustekinumab Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Ustekinumab Sales Market Share by Application (2016-2026)
Figure 75. Middle East & Africa Ustekinumab Sales Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Ustekinumab Revenue Market Share by Country (2016-2026)
Figure 77. Turkey Ustekinumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Egypt Ustekinumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Saudi Arabia Ustekinumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. South Africa Ustekinumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
全身性エリテマトーデス（SLE）薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 SLE is the most common form of lupus and is also called lupus. It is a chronic, autoimmune disease with signs and symptoms that can last for six months or for many years. It can affect any part of the body, such as the skin, joints, and organs (LFA, 2012). SLE occurs when the immune system produces …- 肝硬変治療の世界市場2018-2025 In 2018, the global Liver Cirrhosis Therapeutics market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Liver Cirrhosis Therape…
- 世界の肝硬変テスター市場 2021：企業別、地域別、種類・用途別 The Cirrhosis Tester market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, r…
- 自己免疫薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body lead to autoimmune diseases. These diseases are characterized by c…
- 世界の超音波肝硬変検知器市場 2021：企業別、地域別、種類・用途別 The Ultrasound Cirrhosis Detectors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …